These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18677401)

  • 1. Immune response to lytic peptides conjugated to a betaCG fragment in treated BALB/C mice.
    Bogacki M; Enright FM; Todd WJ; Hansel W
    Reprod Biol; 2008 Jul; 8(2):135-47. PubMed ID: 18677401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Destruction of breast cancers and their metastases by lytic peptide conjugates in vitro and in vivo.
    Hansel W; Enright F; Leuschner C
    Mol Cell Endocrinol; 2007 Jan; 260-262():183-9. PubMed ID: 17101210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting breast and prostate cancers through their hormone receptors.
    Leuschner C; Hansel W
    Biol Reprod; 2005 Nov; 73(5):860-5. PubMed ID: 16033998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane disrupting lytic peptide conjugates destroy hormone dependent and independent breast cancer cells in vitro and in vivo.
    Leuschner C; Enright FM; Gawronska B; Hansel W
    Breast Cancer Res Treat; 2003 Mar; 78(1):17-27. PubMed ID: 12611453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted destruction of normal and cancer cells through lutropin/choriogonadotropin receptors using Hecate-betaCG conjugate.
    Zaleska M; Bodek G; Jana B; Hansel W; Ziecik AJ
    Exp Clin Endocrinol Diabetes; 2003 May; 111(3):146-53. PubMed ID: 12784188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugates of lytic peptides and LHRH or betaCG target and cause necrosis of prostate cancers and metastases.
    Hansel W; Leuschner C; Enright F
    Mol Cell Endocrinol; 2007 Apr; 269(1-2):26-33. PubMed ID: 17382461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of Phor21-betaCG(ala), a lytic peptide conjugate.
    Jia L; Noker PE; Piazza GA; Leuschner C; Hansel W; Gorman GS; Coward LU; Tomaszewski J
    J Pharm Pharmacol; 2008 Nov; 60(11):1441-8. PubMed ID: 18957164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo.
    Gawronska B; Leuschner C; Enright FM; Hansel W
    Gynecol Oncol; 2002 Apr; 85(1):45-52. PubMed ID: 11925119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapy for adrenocortical tumors in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin beta conjugate.
    Vuorenoja S; Rivero-Müller A; Ziecik AJ; Huhtaniemi I; Toppari J; Rahman NA
    Endocr Relat Cancer; 2008 Jun; 15(2):635-48. PubMed ID: 18509010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice.
    Bodek G; Vierre S; Rivero-Müller A; Huhtaniemi I; Ziecik AJ; Rahman NA
    Neoplasia; 2005 May; 7(5):497-508. PubMed ID: 15967102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate.
    Bodek G; Rahman NA; Zaleska M; Soliymani R; Lankinen H; Hansel W; Huhtaniemi I; Ziecik AJ
    Breast Cancer Res Treat; 2003 May; 79(1):1-10. PubMed ID: 12779076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hecate-CGbeta conjugate and gonadotropin suppression shows two distinct mechanisms of action in the treatment of adrenocortical tumors in transgenic mice expressing Simian Virus 40 T antigen under inhibin-alpha promoter.
    Vuorenoja S; Mohanty BP; Arola J; Huhtaniemi I; Toppari J; Rahman NA
    Endocr Relat Cancer; 2009 Jun; 16(2):549-64. PubMed ID: 19261682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human prostate cancer cells and xenografts are targeted and destroyed through luteinizing hormone releasing hormone receptors.
    Leuschner C; Enright FM; Gawronska-Kozak B; Hansel W
    Prostate; 2003 Sep; 56(4):239-49. PubMed ID: 12858351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of hecate-chorionic gonadotropin beta conjugate in therapy of lutenizing hormone receptor expressing gonadal somatic cell tumors.
    Rivero-Müller A; Vuorenoja S; Tuominen M; Wacławik A; Brokken LJ; Ziecik AJ; Huhtaniemi I; Rahman NA
    Mol Cell Endocrinol; 2007 Apr; 269(1-2):17-25. PubMed ID: 17363137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted ablation of prostate carcinoma cells through LH receptor using Hecate-CGbeta conjugate: functional characteristic and molecular mechanism of cell death pathway.
    Bodek G; Kowalczyk A; Waclawik A; Huhtaniemi I; Ziecik AJ
    Exp Biol Med (Maywood); 2005 Jun; 230(6):421-8. PubMed ID: 15956772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted destruction of prostate cancer cells and xenografts by lytic peptide-betaLH conjugates.
    Hansel W; Leuschner C; Gawrońska B; Enright F
    Reprod Biol; 2001 Jul; 1(1):20-32. PubMed ID: 14666172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of monoclonal anti-alpha-human chorionic gonadotropin antibody.
    Gupta SK; Singh O; Kaur I; Talwar GP
    Indian J Med Res; 1985 Mar; 81():281-5. PubMed ID: 2410360
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth repression in diethylstilbestrol/dimethylbenz[a]anthracene-induced rat mammary gland tumor using Hecate-CGbeta conjugate.
    Zaleska M; Waclawik A; Bodek G; Zezula-Szpyra A; Li X; Janowski T; Hansel WH; Rahman NA; Ziecik AJ
    Exp Biol Med (Maywood); 2004 Apr; 229(4):335-44. PubMed ID: 15044717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monoclonal antibodies against the beta subunit of human chorionic gonadotropin].
    Fidler R; Sokolov AV; Verbitskiĭ MSh; Papazov IP
    Biull Eksp Biol Med; 1988 Dec; 106(12):693-5. PubMed ID: 2462933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human chorionic gonadotropin beta-core fragment is directly produced by cancer cells.
    Okamoto T; Niu R; Matsuo K; Furuhashi M; Ohsawa M; Mizutani S; Suzuki H
    Life Sci; 2001 Jan; 68(8):861-72. PubMed ID: 11213356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.